2-111769289-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_022662.4(ANAPC1):c.*2C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.217 in 1,603,028 control chromosomes in the GnomAD database, including 38,764 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.18 ( 2650 hom., cov: 27)
Exomes 𝑓: 0.22 ( 36114 hom. )
Consequence
ANAPC1
NM_022662.4 3_prime_UTR
NM_022662.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.240
Genes affected
ANAPC1 (HGNC:19988): (anaphase promoting complex subunit 1) This gene encodes a subunit of the anaphase-promoting complex. This complex is an E3 ubiquitin ligase that regulates progression through the metaphase to anaphase portion of the cell cycle by ubiquitinating proteins which targets them for degradation. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 2-111769289-G-A is Benign according to our data. Variant chr2-111769289-G-A is described in ClinVar as [Benign]. Clinvar id is 1188976.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.227 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANAPC1 | NM_022662.4 | c.*2C>T | 3_prime_UTR_variant | 48/48 | ENST00000341068.8 | NP_073153.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANAPC1 | ENST00000341068 | c.*2C>T | 3_prime_UTR_variant | 48/48 | 1 | NM_022662.4 | ENSP00000339109.3 | |||
ANAPC1 | ENST00000427997.5 | c.4322-2294C>T | intron_variant | 1 | ENSP00000396695.1 | |||||
ANAPC1 | ENST00000462785.1 | n.2531C>T | non_coding_transcript_exon_variant | 4/4 | 2 | |||||
ANAPC1 | ENST00000643447.1 | n.746-2294C>T | intron_variant | ENSP00000494863.1 |
Frequencies
GnomAD3 genomes AF: 0.178 AC: 26923AN: 151246Hom.: 2648 Cov.: 27
GnomAD3 genomes
AF:
AC:
26923
AN:
151246
Hom.:
Cov.:
27
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.204 AC: 49851AN: 244616Hom.: 5421 AF XY: 0.212 AC XY: 27979AN XY: 132278
GnomAD3 exomes
AF:
AC:
49851
AN:
244616
Hom.:
AF XY:
AC XY:
27979
AN XY:
132278
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.221 AC: 320388AN: 1451662Hom.: 36114 Cov.: 30 AF XY: 0.221 AC XY: 159817AN XY: 721538
GnomAD4 exome
AF:
AC:
320388
AN:
1451662
Hom.:
Cov.:
30
AF XY:
AC XY:
159817
AN XY:
721538
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.178 AC: 26935AN: 151366Hom.: 2650 Cov.: 27 AF XY: 0.175 AC XY: 12932AN XY: 73902
GnomAD4 genome
AF:
AC:
26935
AN:
151366
Hom.:
Cov.:
27
AF XY:
AC XY:
12932
AN XY:
73902
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Rothmund-Thomson syndrome type 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at